INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Jérôme Fayette(Université Claude Bernard Lyon 1), Helena Rebelo‐de‐Andrade(University of Lisbon), Paul M. Clément(Universitair Ziekenhuis Leuven), Lúcia Águas, Stefan Kasper(Essen University Hospital), Tanguy Y. Seiwert(Georgetown University), Makoto Tahara(National Cancer Center Hospital East), Robert L. Metcalf(The Christie NHS Foundation Trust), Jessica R. Bauman, Paolo Bossi(Humanitas University), Tsung-Ming Chen, Anirudha Dasgupta, Maureen Bernadach, Myung‐Ju Ahn(Sungkyunkwan University), Lisa Licitra(University of Milan), Santiago Cabezas Camarero, Ann Hoeben(Maastricht University Medical Centre), Danny Rischin(Peter MacCallum Cancer Centre), Amanda Psyrri(National and Kapodistrian University of Athens), Douglas R. Adkins(Washington University in St. Louis), Jorge Blando(AstraZeneca (Netherlands)), Ulrich Keilholz(German Cancer Research Center), Jean‐Pascal Machiels(Cliniques Universitaires Saint-Luc), José Dinis(Instituto Português de Oncologia Francisco Gentil), Michael S. Hwang(Howard Hughes Medical Institute), Vyacheslav Chubenko, Federica Bertolini, Kevin J. Harrington(Royal Marsden NHS Foundation Trust), А. М. Мудунов(Italian Society of Periodontology and Implantology), Michael Boyer(Chris O’Brien Lifehouse), Dario Ruscica(AstraZeneca (United Kingdom)), Bhumsuk Keam(Seoul National University Hospital), Robert I. Haddad(Georgetown University), Konrad Klinghammer(Charité - Universitätsmedizin Berlin), Amaury Daste(Centre Hospitalier Universitaire de Bordeaux), Robert L. Ferris(University of Pittsburgh), Yi‐Chun Liu(Stomatology Hospital), P. A. Isaev(Medical Radiological Research Center), Paul Clement(KU Leuven), Christian Borel, Ching-Yun Hsieh(China Medical University), Wonyoung Choi, Roger B. Cohen(University of Pennsylvania), Lillian L. Siu(University Health Network), Olivier Serrano(AstraZeneca (France)), Marcelo Bonomi
Cited by 26
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k